期刊文献+

血清胱抑素C联合尿液α1-MG、mALB检测对慢性肾炎早期肾功能损伤的诊断价值分析 被引量:3

Diagnostic Value of Serum Cystatin C Combined with Urine α1-MG and mALB for Early Renal Damage in Patients with Chronic Nephritis
下载PDF
导出
摘要 目的 分析血清胱抑素C(Cys-C)联合尿α1-微球蛋白(α1-MG)、尿微量白蛋白(mALB)检测对慢性肾炎早期肾功能损伤的诊断价值。方法 将我院自2014年1月至2018年3月收治的104例慢性肾炎患者纳入研究,并参照K/DOQI进行临床分期;另筛选同期于我院行常规体检的60例健康对象设为对照组,对比其血清Cys-C、尿α1-MG、mALB水平,分析其与肾小球滤过率公式估算值(eGFR)的相关性;并分析血清Cys-C联合尿α1-MG、mALB检测对慢性肾炎早期肾功能损伤的诊断价值。结果 慢性肾炎Ⅰ期、Ⅱ期、Ⅲ期及对照组血清Cys-C、尿α1-MG、mALB比较差异均有统计学意义(P<0.05),且血清Cys-C、尿α1-MG、mALB水平随分期增加而上升(P<0.05);经Pearson相关性分析,血清Cys-C、尿α1-MG及mALB均与eGFR呈负相关(r=-0.823、-0.757、-0.719,P<0.001);以eGFR=60mL/min·1.73m2为肾损伤阀值绘制ROC曲线,单一血清Cys-C、尿α1-MG、尿mALB及联合诊断时,ROC曲线下面积(AUC)为0.805、0.789、0.700、0.904,联合诊断敏感度、特异度、阳性预测值及阴性预测值最佳,依次为86.29%、78.80%、87.29%、67.22%。结论 慢性肾炎早期肾功能损伤,血清Cys-C联合尿α1-MG、mALB检测或具更高的诊断获益,值得临床重视。 Objective To analyze the diagnostic value of serum cystatin C(Cys-C)combined with urine α1-microglobulin(α1-MG)and urine microalbumin(mALB)for early renal damage in patients with chronic nephritis.Methods 104 patients with chronic nephritis who were admitted to the hospital during the period from January 2014 to March 2018 were enrolled in the study.Referring to K/DOQI,clinical staging was carried out.Another 60 healthy subjects who received routine physical examined in the hospital during the same period were selected as the control group.Levels of serum Cys-C,urine α1-MG and urine mALBwere compared,and their correlation with eGFR was analyzed.The diagnostic value of serum cystatin C combined with urine α1-MG and mALB for early renal damage in patients with chronic nephritis was also analyzed.Results There were significant differences in serum Cys-C,urine α1-MG and urine mALB between patients with stage I,stage II and stage III chronic nephritisand control group(P<0.05),and levels of serum Cys-C,urine α1-MG and urine mALB increased with the increase of stage(P<0.05).Pearson correlation analysis showed that serum Cys-C,urine α1-MG and mALB were significantly negatively correlated with glomerular filtration rate(eGFR)(r=-0.823,-0.757,-0.719,all P<0.001).ROC curve was drawn with eGFR=60ml/min/1.73m2as the threshold of renal damage.The areas under ROC curves(AUC)of single serum Cys-C,urine α1-MG,urine mALB and combined diagnosis were 0.805,0.789,0.700and 0.904,respectively.Thesensitivity,specificity,positive predictive valueand negative predictive value of combined diagnosis were the best(86.29%,78.80%,87.29%and 67.22%).Conclusion Serum Cys-C combined with urine α1-MG and urine mALBis of higher diagnostic value for early renal damage in patients with chronic nephritis.
作者 李周齐 李华彬 Li Zhouqi;Li Huabin(Chengdu Tianfu New District People's Hospital ,Chengdu 610222,China)
出处 《哈尔滨医药》 2019年第4期304-306,共3页 Harbin Medical Journal
关键词 血清胱抑素C 尿液α1-MG MALB 慢性肾炎 肾功能损伤 Serum cystatin C Urine α1-MG MALB Chronic nephritis Renaldamage
  • 相关文献

参考文献7

二级参考文献103

  • 1贾敬华,汝颖,王长江,胡红琳.尿白蛋白/肌酐比值在早期2型糖尿病肾病中的诊断价值[J].安徽医科大学学报,2006,41(1):107-109. 被引量:8
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:710
  • 3祁金友.糖尿病患者血清中胱抑素C含量测定的临床意义[J].检验医学与临床,2007,4(1):35-36. 被引量:18
  • 4Lemann J Jr, Dourmas BT. Proteinaria in health and disease by measuring the urinary protein/creatinine ratio [ J ]. Clin Chem, 1987,33 (2) :279-299.
  • 5Perlemoine C, Beauvieux MC, Rigalleau V, et al. Interest of cys- tatin C in screening disbetic patients for early impairment of renal function[ J ]. Metabolism, 2003,52 (10) : 1258-1264.
  • 6Xia LH, Bing XG, An XT. Serum cystatinC assay for the detection of early renal impairment in diabetic patients[ J]. J Clin Lab Anal, 2004,18( 1 ) :31-35.
  • 7de Sain-van der Velden MG, Kaysen GA, Barrett HA, et al. In- creased VLDL in nephritic patients results from a decreased catabo- lism while increased LDL results from increased synthesis [ J ]. Kidney Int, 1998,53 (4) :994-1001.
  • 8陆汉魁.应用放射性核素方法测量肾小球滤过率及相关技术问题[J].中华检验医学杂志,2007,30(11):1211-1212. 被引量:9
  • 9Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes[ J]. Kidney Int, 2007, 72: 247-259.
  • 10Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease:Improving Global Outcomes (KDIGO)[ J]. Kidney [nt, 2005, 67: 2089-2100.

共引文献108

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部